Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Vinblastine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 53 Lymphoma 33 Urinary Bladder Neoplasms 14 Melanoma 9 Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 7 Recurrence 4 Prostatic Neoplasms 4 Lymphoma, Large-Cell, Anaplastic 4 Urethral Neoplasms 3 Neoplasms 3 Glioma 3 Astrocytoma 3 Testicular Neoplasms 2 Skin Neoplasms 2 Oligodendroglioma 2 Leukemia 2 Kidney Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Testicular Germ Cell Tumor 1 Teratoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1

Interventions

Rituximab 342 Cyclophosphamide 303 Vincristine 149 Prednisone 147 Doxorubicin 145 Etoposide 141 Filgrastim 96 Peripheral Blood Stem Cell Transplantation 90 Lenalidomide 88 fludarabine phosphate 73 Radiotherapy 68 Cytarabine 65 Gemcitabine 63 Methotrexate 51 Mycophenolic Acid 50 Cyclosporine 50 Melphalan 49 Ifosfamide 47 fludarabine 45 Busulfan 45 Carmustine 44 Whole-Body Irradiation 40 Oxaliplatin 40 Tacrolimus 38 Carboplatin 38 Antilymphocyte Serum 34 polatuzumab vedotin 33 Magnetic Resonance Spectroscopy 33 Dexamethasone 33 Bendamustine Hydrochloride 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01148446 2010-06-22

ANZINTER3

Fondazione Italiana Linfomi - ETS

Phase 3 Completed

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡